Skip to content

Illumina Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 29, 2026 results vs estimates

Illumina Inc · E.ILMN.NASDAQ · United States
Use symbol E.ILMN.NASDAQ in our API & Excel add-in to retrieve this data ↓
290.06
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 55.07%

Illumina Inc Forecast

Illumina Inc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 55.1% a year, a typical one-standard-deviation range is 267.56–312.56 over a week, 243.95–336.17 over a month and 130.33–449.79 over a year. (Signals as of 1 Nov 2026.)

Illumina Inc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Illumina Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Illumina Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Illumina Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Illumina Inc
P/E
49.91x
Mid-range vs own history
QoQ +22.7%
YoY +84.0%
now 49.909821.16 low51.59 high
ⓘP/E As of 22 Nov 2026.See Illumina Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Illumina Inc
P/S
9.84x
Stretched vs own history
QoQ +31.7%
YoY +121.1%
now 9.84344.14 low9.84 high
ⓘP/S As of 22 Nov 2026.See Illumina Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Illumina Inc
P/B
14.20x
Stretched vs own history
QoQ +20.1%
YoY +77.3%
now 14.20336.61 low15 high
ⓘP/B As of 22 Nov 2026.See Illumina Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Illumina Inc
EV/EBITDA
33.20x
Mid-range vs own history
QoQ +28.5%
YoY +105.3%
now 33.196513.07 low33.2 high
ⓘEV/EBITDA As of 22 Nov 2026.See Illumina Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Illumina Inc
EV/Sales
10.06x
Stretched vs own history
QoQ +29.4%
YoY +111.6%
now 10.05844.36 low10.06 high
ⓘEV/Sales As of 22 Nov 2026.See Illumina Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Illumina Inc
FCF Yield
2.4%
Mid-range vs own history
QoQ −14.7%
YoY −54.9%
now 2.36632.19 low5.42 high
ⓘFCF Yield As of 22 Nov 2026.See Illumina Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Illumina Inc
Earnings Yield
2.0%
Mid-range vs own history
QoQ −18.5%
YoY −45.6%
now 2.00361.94 low4.73 high
ⓘEarnings Yield As of 22 Nov 2026.See Illumina Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Illumina Inc
Market Cap
$44.7B
Highest in 5 years
QoQ +33.1%
YoY +134.2%
now 44669.2417,989 low44,669 high
ⓘMarket Cap As of 22 Nov 2026.See Illumina Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Illumina Inc
Net Debt
$976M
Low vs own history
QoQ −28.2%
YoY −24.8%
now 976920 low1,389 high
ⓘNet Debt As of 22 Nov 2026.See Illumina Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Illumina Inc
Net Debt / EBITDA
0.71x
Low vs own history
QoQ −29.4%
YoY −31.1%
now 0.70980.64 low1.03 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Illumina Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Illumina Inc
Current Ratio
2.63x
Strong vs own history
QoQ +46.2%
YoY +84.2%
now 2.62541.43 low2.63 high
ⓘCurrent Ratio As of 22 Nov 2026.See Illumina Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Illumina Inc
Quick Ratio
2.05x
Strong vs own history
QoQ +46.6%
YoY +82.2%
now 2.04841.12 low2.05 high
ⓘQuick Ratio As of 22 Nov 2026.See Illumina Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Illumina Inc
Debt / Equity
0.74x
Mid-range vs own history
QoQ −17.4%
YoY −32.0%
now 0.73550.74 low1.08 high
ⓘDebt / Equity As of 22 Nov 2026.See Illumina Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Illumina Inc
Piotroski F-Score
8
Strong vs own history
QoQ +33.3%
YoY 0.0%
now 86 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Illumina Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Illumina Inc
Altman Z-Score
8.87
Strong vs own history
QoQ +32.2%
YoY +109.7%
now 8.87274.13 low8.87 high
ⓘAltman Z-Score As of 22 Nov 2026.See Illumina Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Illumina Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Illumina Inc fundamentals: income statement, balance sheet & cash flow

Illumina Inc reported revenue of $4.34bn and net income of $850.0m in FY2025, the year ended 31 December 2025 — revenue down 0.7% and net income up 169.5% on the prior year. Free cash flow was $931.0m. These figures are as reported in the filings, not restated: 27 fiscal years and 107 quarters of history, back to December 1999. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$4.34bn
-0.7%
Net income
$850.0m
+169.5%
Gross margin
66.08%
Free cash flow
$931.0m
+31.3%
Net debt
$1.14bn
Shares short (30 Oct 2026)
8.02m
3.67 days to cover
Illumina Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue4,343.04,372.04,504.04,584.04,526.0
Cost of revenue1,473.01,511.01,760.01,612.01,372.0
Gross profit2,870.02,861.02,744.02,972.03,154.0
Research & development967.01,169.01,354.01,321.01,185.0
Selling, general & admin.1,086.02,525.0—5,830.02,092.0
Operating income807.0-833.0-1,069.0-4,179.0-123.0
EBITDA1,417.0-725.0-1,069.0-3,785.0128.0
Interest expense101.0100.077.026.061.0
Pre-tax income1,086.0-1,179.0-1,117.0-4,336.0884.0
Income tax236.044.044.068.0122.0
Net income850.0-1,223.0-1,161.0-4,404.0762.0

Download Illumina Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.ILMN.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 27 fiscal years and 107 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Illumina Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Illumina Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Illumina Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Illumina Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Illumina Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Illumina Inc (United States)

Illumina Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Illumina Inc?
Illumina Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Illumina Inc price?
The latest close is 290.06 (1 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Illumina Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Illumina Inc?
20-day realised volatility is 55.1% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 15.9% over a month and 7.8% over a week.
What factors affect Illumina Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Illumina Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Illumina Inc?
58 backtested tactical asset allocation strategies trade Illumina Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Illumina Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Illumina Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Illumina Inc historical data?
In the Free historical data section of this page: the last 10 years of Illumina Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Illumina Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Illumina Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ILMN.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20192.82
2026-11-19200.655
2026-11-18210.01
2026-11-17202.61
2026-11-16198
2026-11-13207.01
2026-11-12209.55
2026-11-11212.93
2026-11-10214.91
2026-11-09220.78
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.